An Extension Study to Assess the Long-term Safety and Efficacy ofVamorolone in Boys With Duchenne Muscular Dystrophy(DMD) An Extension Study to Assess the Long-term Safety and Efficacy ofVamorolone in Boys With Duchenne Mu ...
A 24-month Phase II Open-label, Multicenter Long-term Extension Study toAssess the Long-term Safety and Efficacy of Vamorolone in Boys withDuchenne Muscular Dystrophy (DMD) - VBP15-LTE A 24-month Phase II Open-label, Multicenter Long-term Extension Study toAssess the Long-term Safety ...
Product Name: Vamorolone INN or Proposed INN: Vamorolone Other descriptive name: EVsubstancecode:SUB188638 Product Name: Vamorolone INN or Proposed INN: Vamorolone Other descriptive name: EVsubstancecode:SUB188638 Product Name: Vamorolone INN or Proposed INN: Vamorolone Other descriptive name: EVsubstancecode:SUB188638 Product Name: Vamorolone INN or Proposed INN: Vamorolone Other descriptive name: EVsubstancecode:SUB188638Product Name: Vamorolone INN or Proposed INN: Vamorolone Other descriptive name: EVsubstancecode:SU ...
ReveraGen BioPharma Inc.
NULL
Not Recruiting
Female: no Male: yes
48
Phase 2
United States;Canada;Australia;Israel;United Kingdom;Sweden